BioLineRx Total Risk Alpha
| BLRX Stock | | | USD 2.71 0.08 3.04% |
Reference data associated with the Total Risk Alpha technical indicator for BioLineRx. Indicator inputs depend on available historical price observations.
BioLineRx has current Total Risk Alpha of
-0.15. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | -0.15 | |
| ER[a] | = | Expected return on investing in BioLineRx |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on BioLineRx |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
BioLineRx is rated
below average in total risk alpha among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare BioLineRx to Peers
Other Technical Indicators